Advertisement

Advertisement

ETON Stock Latest News

Eton Shareholders Back Board Nominees and Auditor Selection

Company AnnouncementsEton Shareholders Back Board Nominees and Auditor Selection

Eton Pharmaceuticals: Buy Rating Reiterated as Strategic IMPAVIDO Deal Supports Asset-Light Growth and Unchanged $57 Price Target

PremiumRatings

Eton Pharmaceuticals: Buy Rating Reiterated as Strategic IMPAVIDO Deal Supports Asset-Light Growth and Unchanged $57 Price Target

1M ago

Eton Pharmaceuticals Signals Strong Momentum in Earnings Call

PremiumCompany Announcements

Eton Pharmaceuticals Signals Strong Momentum in Earnings Call

1M ago

Eton Pharmaceuticals Secures U.S. Rights to IMPAVIDO

PremiumCompany Announcements

Eton Pharmaceuticals Secures U.S. Rights to IMPAVIDO

1M ago

Eton Pharmaceuticals enters supply, distribution agreement for Impavido

PremiumThe Fly

Eton Pharmaceuticals enters supply, distribution agreement for Impavido

1M ago

Eton Pharmaceuticals Signals Strong Momentum In Earnings

PremiumCompany AnnouncementsEton Pharmaceuticals Signals Strong Momentum In Earnings

1M ago

Eton Pharmaceuticals price target raised to $57 from $52 at H.C. Wainwright

The Fly

Eton Pharmaceuticals price target raised to $57 from $52 at H.C. Wainwright

1M ago

ETON Earnings Report this Week: Is It a Buy, Ahead of Earnings?

Pre-Earnings

ETON Earnings Report this Week: Is It a Buy, Ahead of Earnings?

1M ago

Eton Pharmaceuticals Relaunches HEMANGEOL With Exclusive Distribution

PremiumCompany Announcements

Eton Pharmaceuticals Relaunches HEMANGEOL With Exclusive Distribution

2M ago

Eton Pharmaceuticals announces relaunch of Hemangeol

PremiumThe Fly

Eton Pharmaceuticals announces relaunch of Hemangeol

2M ago

Eton Starts Pilot Trial of ET-700 for Wilson Disease

PremiumCompany Announcements

Eton Starts Pilot Trial of ET-700 for Wilson Disease

2M ago

Eton Pharmaceuticals says first patient dosed in study of ET-700

PremiumThe Fly

Eton Pharmaceuticals says first patient dosed in study of ET-700

2M ago

Eton Pharmaceuticals Announces New Chief Financial Officer Appointment

PremiumCompany AnnouncementsEton Pharmaceuticals Announces New Chief Financial Officer Appointment

2M ago

Eton Pharmaceuticals appoints Judith Matthews as CFO

The Fly

Eton Pharmaceuticals appoints Judith Matthews as CFO

2M ago

Eton Pharmaceuticals Amends Credit Agreement, Eases Debt Terms

Company Announcements

Eton Pharmaceuticals Amends Credit Agreement, Eases Debt Terms

2M ago

Eton Pharmaceuticals Maps Aggressive Rare-Disease Growth Path

PremiumCompany Announcements

Eton Pharmaceuticals Maps Aggressive Rare-Disease Growth Path

3M ago

Eton Pharmaceuticals price target raised to $52 from $37 at H.C. Wainwright

PremiumThe Fly

Eton Pharmaceuticals price target raised to $52 from $37 at H.C. Wainwright

3M ago

Eton Pharmaceuticals: Expanding Rare-Disease Portfolio Underpins Attainable Growth Targets and Upside to $52 Price Target

PremiumRatings

Eton Pharmaceuticals: Expanding Rare-Disease Portfolio Underpins Attainable Growth Targets and Upside to $52 Price Target

3M ago

Eton Pharmaceuticals price target raised to $35 from $30 at Craig-Hallum

PremiumThe Fly

Eton Pharmaceuticals price target raised to $35 from $30 at Craig-Hallum

3M ago

Eton Pharmaceuticals price target raised to $31 from $26 at B. Riley

PremiumThe FlyEton Pharmaceuticals price target raised to $31 from $26 at B. Riley

3M ago

Eton Pharmaceuticals reports Q4 EPS 5c vs. (2c) last year

The Fly

Eton Pharmaceuticals reports Q4 EPS 5c vs. (2c) last year

3M ago

Eton Pharmaceuticals sees FY26 revenue at least $110M, consensus $105.25M

The Fly

Eton Pharmaceuticals sees FY26 revenue at least $110M, consensus $105.25M

3M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >